Clinical Trial Update: Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas [Phase 3]

View source ↗

Summary

A Phase III study comparing ABI-007 (albumin-bound paclitaxel) plus gemcitabine versus gemcitabine alone in metastatic pancreatic cancer has completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• ABI-007 (albumin-bound paclitaxel) (paclitaxel albumin-bound)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Celgene | Conditions: Metastatic Pancreatic Cancer | Phase 3 | Status: COMPLETED | Results posted: 2013-12-11